Influence of Physical Activity on Hypertension and Cardiac Structure and Function

Current Hypertension Reports

Volumn 17, Issue 10, 2015, Pages

  Hegde, Sheila M ^a   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiac remodeling; Hypertension; Physical activity

Indexed keywords

MICRORNA;

ADRENERGIC SYSTEM; ATHLETE; BLOOD PRESSURE; CARDIOVASCULAR RISK; EXERCISE; FIBROSIS; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTENSION; HYPERTROPHY; MORBIDITY; MORTALITY; PHYSICAL ACTIVITY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TURNOVER TIME; ANIMAL; CARDIOVASCULAR DISEASES; HYPERTROPHY, LEFT VENTRICULAR; MOTOR ACTIVITY; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; FIBROSIS; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MOTOR ACTIVITY; RISK FACTORS;

EID: 84939230158     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-015-0588-3     Document Type: Review

References (87)

1. Campbell NRC, Lackland DT, Niebylski ML, the World Hypertension League and International Society of Hypertension Executive Committees. High blood pressure: why prevention and control are urgent and important—a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension. J Clin Hypertens. 2014;16:551–3.
2. Cuspidi C, Facchetti R, Bombelli M, Sala C, Tadic M, Grassi G, et al. Prognostic value of left ventricular mass normalized to different body size indexes: findings from the PAMELA population. J Hypertens. 2015;33:1082–9.
3. Pierdomenico SD, Lapenna D, Cuccurullo F. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension. Am J Hypertens. 2008;21:464–70.
4. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21:500–8.
5. Rodilla E, Pascual JM, Costa JA, Martin J, Gonzalez C, Redon J. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens. 2013;31:1683–91.
6. Diaz KM, Shimbo D. Physical activity and the prevention of hypertension. Curr Hypertens Rep. 2013;15:659–68.
7. Cornelissen VA, Fagard RH. Effects of endurance training on blood pressure, blood pressure–regulating mechanisms, and cardiovascular risk factors. Hypertension. 2005;46:667–75.
8. Leitzmann MF, Park Y, Blair A, et al. Physical activity recommendations and decreased risk of mortality. Arch Intern Med. 2007;167:2453–60.
9. Rossi A, Dikareva A, Bacon SL, Daskalopoulou SS. The impact of physical activity on mortality in patients with high blood pressure: a systematic review. J Hypertens. 2012;30:1277–88.
10. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (jnc 8). JAMA. 2014;311:507–20.
11. Members AF, Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159–219.
12. Mendis S, World Health Organization. Global status report on noncommunicable diseases 2014. 2014.
13. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. Exercise and hypertension. Med Sci Sports Exerc. 2004;36:533–53.
14. Fagard RH. Exercise therapy in hypertensive cardiovascular disease. Prog Cardiovasc Dis. 2011;53:404–11.
15. Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta‐analysis. J Am Heart Assoc. 2013;2, e004473. A systematic review and meta-analysis of 93 studies summarizing the effects of exercise on resting blood pressure.
16. Carlson DJ, Dieberg G, Hess NC, Millar PJ, Smart NA. Isometric exercise training for blood pressure management: a systematic review and meta-analysis. Mayo Clin Proc. 2014;89:327–34.
17. Pescatello LS. Exercise and hypertension: recent advances in exercise prescription. Curr Hypertens Rep. 2005;7:281–6.
18. Ash GI, Eicher JD, Pescatello LS. The promises and challenges of the use of genomics in the prescription of exercise for hypertension: the 2013 update. Curr Hypertens Rev. 2013;9:130–47.
19. Hamer M. The anti-hypertensive effects of exercise: integrating acute and chronic mechanisms. Sports Med Auckl NZ. 2006;36:109–16.
20. Semlitsch T, Jeitler K, Hemkens LG, Horvath K, Nagele E, Schuermann C, et al. Increasing physical activity for the treatment of hypertension: a systematic review and meta-analysis. Sports Med. 2013;43:1009–23. A systematic review and meta-analysis of 9 studies summarizing the impact of physical activity on treatment of hypertension.
21. Pescatello LS, Blanchard BE, Tsongalis GJ, O’Connell AA, Gordish-Dressman H, Maresh CM, et al. A comparison of the genetic and clinical profile of men that respond and do not respond to the immediate antihypertensive effects of aerobic exercise. Appl Clin Genet. 2008;1:7–17.
22. Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling mechanisms: part 1 of 2. Circulation. 2013;128:388–400.
23. Wachtell K, Dahlöf B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, et al. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Am Heart J. 2002;144:1057–64.
24. Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size. Tthe Framingham Heart Study. Hypertension. 1995;25:1155–60.
25. Cuspidi C, Rescaldani M, Sala C. Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies. Am J Hypertens. 2013;26:456–64.
26. De Simone G. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. Eur Heart J. 2005;26:1039–45.
27. Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C, et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study. J Hypertens. 2005;23:875–82.
28. Wachtell K, Smith G, Gerdts E, Dahlöf B, Nieminen MS, Papademetriou V, et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)∗. Am J Cardiol. 2000;85:466–72.
29. Matsuda M, Matsuda Y. Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertension. Clin Cardiol. 1996;19:954–9.
30. Cuspidi C, Sala C, Muiesan ML, De Luca N, Schillaci G. Right ventricular hypertrophy in systemic hypertension: an updated review of clinical studies. J Hypertens. 2013;31:858–65.
31. Cuspidi C, Negri F, Giudici V, Valerio C, Meani S, Sala C, et al. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension. J Hypertens. 2009;27:854–60.
32. Morganroth J, Maron BJ, Henry WL, Epstein SE. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82:521–4.
33. Pelliccia A, Maron MS, Maron BJ. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete’s heart from pathologic hypertrophy. Prog Cardiovasc Dis. 2012;54:387–96. A review detailing the spectrum of cardiac remodeling in the athlete's heart compared hypertrophic cardiomyopathy.
34. Baggish AL, Wang F, Weiner RB, Elinoff JM, Tournoux F, Boland A, et al. Training-specific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athletes. J Appl Physiol. 2008;104:1121–8.
35. Weiner RB, Wang F, Isaacs SK, Malhotra R, Berkstresser B, Kim JH, et al. Blood pressure and left ventricular hypertrophy during american-style football participation. Circulation. 2013;128:524–31.
36. Baggish AL, Yared K, Weiner RB, Wang F, Demes R, Picard MH, et al. Differences in cardiac parameters among elite rowers and sub-elite rowers. Med Sci Sports Exerc. 2009;1.
37. Lauschke J, Maisch B. Athlete’s heart or hypertrophic cardiomyopathy? Clin Res Cardiol. 2009;98:80–8.
38. Utomi V, Oxborough D, Whyte GP, Somauroo J, Sharma S, Shave R, et al. Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete’s. Heart. 2013;99:1727–33. A systematic review and meta-analysis of 92 studies summarizing the cardiac remodeling of the athlete's heart.
39. Naylor LH, George K, O’Driscoll G, Green DJ. The athlete’s heart: a contemporary appraisal of the “Morganroth hypothesis.”. Sports Med Auckl NZ. 2008;38:69–90.
40. Gerche AL, Timothy R, Claessen G. The response of the pulmonary circulation and right ventricle to exercise: exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes (2013 Grover Conference series). Pulm Circ. 2014;4:407–16.
41. Pagourelias ED, Kouidi E, Efthimiadis GK, Deligiannis A, Geleris P, Vassilikos V. Right atrial and ventricular adaptations to training in male Caucasian athletes: an echocardiographic study. J Am Soc Echocardiogr. 2013;26:1344–52.
42. La Gerche A, Burns AT, D’Hooge J, MacIsaac AI, Heidbüchel H, Prior DL. Exercise strain rate imaging demonstrates normal right ventricular contractile reserve and clarifies ambiguous resting measures in endurance athletes. J Am Soc Echocardiogr. 2012;25:253–62.e1.
43. Kovacs R, Baggish AL. Cardiovascular adaptation in athletes. Trends Cardiovasc Med. 2015. A recent review of physiologic vs. pathologic cardiac remodeling of the athlete's heart.
44. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, Pisicchio C, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46:690–6.
45. Rawlins J, Carre F, Kervio G, Papadakis M, Chandra N, Edwards C, et al. Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes. Circulation. 2010;121:1078–85.
46. Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. Athlete’s heart in women: echocardiographic characterization of highly trained elite female athletes. JAMA. 1996;276:211–5.
47. Basavarajaiah S, Boraita A, Whyte G, Wilson M, Carby L, Shah A, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes. J Am Coll Cardiol. 2008;51:2256–62.
48. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012;33:998–1006.
49. Wilson M, O’Hanlon R, Prasad S, Deighan A, MacMillan P, Oxborough D, et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol. 2011;110:1622–6.
50. Knackstedt C, Schmidt K, Syrocki L, Lang A, Bjarnason-Wehrens B, Hildebrandt U, et al. Long-term follow-up of former world-class swimmers: evaluation of cardiovascular function. Heart Vessel. 2015;30:369–78.
51. Pelliccia A, Maron BJ, Luca RD, Paolo FMD, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation. 2002;105:944–9.
52. Maron BJ, Pelliccia A, Spataro A, Granata M. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J. 1993;69:125–8.
53. Weiner RB, Wang F, Berkstresser B, Kim J, Wang TJ, Lewis GD, et al. Regression of “Gray Zone” exercise-induced concentric left ventricular hypertrophy during prescribed detraining. J Am Coll Cardiol. 2012;59:1992–4.
54. Kokkinos PF, Narayan P, Colleran JA, Pittaras A, Notargiacomo A, Reda D, et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med. 1995;333:1462–7.
55. Turner MJ, Spina RJ, Kohrt WM, Ehsani AA. Effect of endurance exercise training on left ventricular size and remodeling in older adults with hypertension. J Gerontol A Biol Sci Med Sci. 2000;55:M245–51.
56. Hinderliter A, Sherwood A, Gullette ED, et al. Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension. Arch Intern Med. 2002;162:1333–9.
57. Boman K, Olofsson M, Dahlöf B, Gerdts E, Nieminen MS, Papademetriou V, et al. Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy (the LIFE Study). Am J Cardiol. 2005;95:280–3.
58. Palatini P, Visentin P, Dorigatti F, Guarnieri C, Santonastaso M, Cozzio S, et al. Regular physical activity prevents development of left ventricular hypertrophy in hypertension. Eur Heart J. 2009;30:225–32. Prospective study demonstrating lower risk of left ventricular hypertrophy in those who exercise compared to sedentary individuals with hypertension.
59. Pitsavos C, Chrysohoou C, Koutroumbi M, Aggeli C, Kourlaba G, Panagiotakos D, et al. The impact of moderate aerobic physical training on left ventricular mass, exercise capacity and blood pressure response during treadmill testing in borderline and mildly hypertensive males. Hell. J Cardiol HJC Hellēnikē Kardiologikē Epitheōrēsē. 2011;52:6–14. Randomized-controlled trial demonstrating a significant decrease in left ventricular mass index in the exercise group.
60. Boman K, Gerdts E, Wachtell K, Dahlöf B, Nieminen MS, Olofsson M, et al. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study. Eur J Cardiovasc Prev Rehabil. 2009;16:242–8.
61. Baglivo HP, Fabregues G, Burrieza H, Esper RC, Talarico M, Esper RJ. Effect of moderate physical training on left ventricular mass in mild hypertensive persons. Hypertension. 1990;15:I153.
62. Reid CM, Dart AM, Dewar EM, Jennings GL. Interactions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects. J Hypertens. 1994;12:291–302.
63. Guirado GN, Damatto RL, Matsubara BB, Roscani MG, Fusco DR, Seki MM, et al. Combined exercise training in asymptomatic elderly with controlled hypertension: effects on functional capacity and cardiac diastolic function. Med Sci Monit. 2012;18:CR461–5.
64. Kelemen MH, Effron MB, Valenti SA, Stewart KJ. Exercise training combined with antihypertensive drug therapy: effects on lipids, blood pressure, and left ventricular mass. Jama. 1990;263:2766–71.
65. Weeks KL, McMullen JR. The athlete’s heart vs. the failing heart: can signaling explain the two distinct outcomes? Physiology. 2011;26:97–105. Overview of signaling mechanisms involved in physiologic and pathologic cardiac remodeling.
66. Ellison GM, Waring CD, Vicinanza C, Torella D. Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart. 2012;98:5–10. Review of signaling mechanisms involved in exercise-induced cardiac remodeling.
67. Mann N, Rosenzweig A. Can exercise teach us how to treat heart disease? Circulation. 2012;126:2625–35. In-depth review of cellular and molecular mechanisms involved in the cardiac response to exercise.
68. Frystyk J. Exercise and the growth hormone-insulin-like growth factor axis. Med Sci Sports Exerc. 2010;42:58–66.
69. McMullen JR, Shioi T, Huang W-Y, Zhang L, Tarnavski O, Bisping E, et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110α) pathway. J Biol Chem. 2004;279:4782–93.
70. Yamashita K, Kajstura J, Discher DJ, Wasserlauf BJ, Bishopric NH, Anversa P, et al. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res. 2001;88:609–14.
71. Serneri GGN, Boddi M, Modesti PA, Cecioni I, Coppo M, Padeletti L, et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res. 2001;89:977–82.
72. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, et al. Akt1 is required for physiological cardiac growth. Circulation. 2006;113:2097–104.
73. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, et al. Phosphoinositide 3-kinase (p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci. 2003;100:12355–60.
74. McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, et al. Protective effects of exercise and phosphoinositide 3-kinase(p110) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci. 2007;104:612–7.
75. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010;128:191–227. In-depth review of the molecular and cellular mechanisms associated with physiologic and pathologic cardiac hypertrophy.
76. Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998;280:574–7.
77. Wettschureck N, Rütten H, Zywietz A, Gehring D, Wilkie TM, Chen J, et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat Med. 2001;7:1236–40.
78. Garciarena CD, Pinilla OA, Nolly MB, Laguens RP, Escudero EM, Cingolani HE, et al. Endurance training in the spontaneously hypertensive rat conversion of pathological into physiological cardiac hypertrophy. Hypertension. 2009;53:708–14.
79. Carneiro-Júnior MA, Pelúzio MCG, Silva CHO, Amorim PRS, Silva KA, Souza MO, et al. Exercise training and detraining modify the morphological and mechanical properties of single cardiac myocytes obtained from spontaneously hypertensive rats. Braz J Med Biol Res. 2010;43:1042–6.
80. Kolwicz SC, MacDonnell SM, Renna BF, Reger PO, Seqqat R, Rafiq K, et al. Left ventricular remodeling with exercise in hypertension. AJP Heart Circ Physiol. 2009;297:H1361–8.
81. Kemi OJ, Wisløff U. Mechanisms of exercise-induced improvements in the contractile apparatus of the mammalian myocardium. Acta Physiol. 2010;199:425–39.
82. Kemi OJ, Ceci M, Condorelli G, Smith GL, Wisloff U. Myocardial sarcoplasmic reticulum Ca2+ ATPase function is increased by aerobic interval training. Eur J Cardiovasc Prev Rehabil. 2008;15:145–8.
83. Collins HL. Daily exercise-induced cardioprotection is associated with changes in calcium regulatory proteins in hypertensive rats. AJP Heart Circ Physiol. 2004;288:H532–40.
84. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98–102.
85. das Neves VJ. Exercise training in hypertension: role of microRNAs. World J Cardiol. 2014;6:713.
86. Wei X, Liu X, Rosenzweig A. What do we know about the cardiac benefits of exercise? Trends Cardiovasc Med. 2014. Review of the clinical and molecular responses underlying the cardiovascular benefits of physical activity.
87. Liu X, Xiao J, Zhu H, Wei X, Platt C, Damilano F, et al. miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab. 2015;21:584–95.